Show summary Hide summary
- Why the partnership ended
- Immediate public reaction and growing backlash
- The company’s new statement after Panettiere’s death
- What the statement said — key points
- How this episode affects brands and mental health conversations
- Voices from advocacy groups and the public
- What to watch next in the debate
Neutrogena has found itself back in the headlines after issuing a new statement following the death of actress Hayden Panettiere. The brand had earlier ended its relationship with Panettiere over remarks she made about postpartum depression, a decision that triggered public backlash. Now, in the wake of her passing, the company has publicly mourned and tried to address the criticism it faced.
Why the partnership ended
Sources say the split began after comments by Panettiere on postpartum depression drew scrutiny. The brand moved quickly to distance itself, citing a misalignment with its values. That decision was framed by Neutrogena as a standard reputational move, not a personal judgement.
Highest lying potential: experts rank the Celebrity Traitors cast using science
Creators transform fashion and beauty: the rise of creator power

Immediate public reaction and growing backlash
The response was swift. Social media users, mental health advocates, and some public figures criticized Neutrogena.
- Critics argued the brand should have engaged in dialogue rather than sever ties.
- Mental health groups said the move risked stigmatizing postpartum struggles.
- Others defended the company’s right to choose partners aligned with its image.
The company’s new statement after Panettiere’s death
Following reports of Panettiere’s death, Neutrogena released a follow-up statement offering condolences. In that message, the company also acknowledged the controversy around the earlier decision and expressed regret for any pain caused.
The statement framed the response as an expression of sympathy and a desire to learn from the episode. It did not, however, provide a detailed explanation of internal deliberations or reverse the original action.
What the statement said — key points
- Condolences: The company expressed sorrow for her death and extended sympathies to family and friends.
- Acknowledgment: Neutrogena noted the public backlash and said it was taking the concerns seriously.
- No policy reversal: The brand stopped short of reinstating any partnership or issuing an apology for the initial decision.
How this episode affects brands and mental health conversations
Experts say the episode highlights the tightrope companies walk when public figures make controversial statements about sensitive topics like postpartum depression. Marketing teams now face pressure to balance corporate values with cultural sensitivity.
- Brands are being urged to consult mental health professionals before responding publicly.
- There is growing demand for thoughtful, restorative approaches rather than immediate severing of ties.
- Public expectation favors open dialogue and education over punitive measures.
Voices from advocacy groups and the public
Mental health organizations reacted by calling for compassion and better public education about postpartum conditions. Some activists used the moment to push for improved support systems for new parents.
Many in the public criticized Neutrogena for handling the situation too abruptly. Others maintain companies must protect their reputations when partners’ views clash with corporate missions.
What to watch next in the debate
Industry watchers will be tracking how other brands respond to similar controversies and whether companies adopt new guidelines for managing partnerships when sensitive topics arise.
- Will brands create formal review processes for partners’ public statements?
- Will mental health advocates gain a larger voice in shaping corporate responses?
- How will public opinion influence future collaborations between companies and celebrities?












